There is evidence that LPA2 is involved in proliferation, apoptosis, drug resistance, metastasis, and the invasion of numerous cancer cells, as well as expression increment in different tumor tissues, including breast, liver, gastric, and colorectal cancers [23–26]. This evidence concerns the gene LPAR2 and cancer.